The only potential saving grace for IBX is if there's a reason they've thrown the hat out for money so soon when CEO has openly said for so long that they have money til trials (I am a holder - albeit a potential very upset one).
I am very much in profit, so 4.5c doesn't concern me and I don't think it was a pump for CR purposes, I think they've chosen to do CR off the back of a raise that was technically sound all the way through, it's just horrible discounting if you ask me.
Potential reasons include: feedback from FDA, Siemens wanting a stake etc.
But if none of those things are in play here, it's an ugly CR and will see the standard drop to CR price and potentially lower.
